Rankings
▼
Calendar
ARGX Q2 2018 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena
ARGX
argenx SE
$45B
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$20M
-16.6% YoY
Gross Profit
-$14M
-67.7% margin
Operating Income
-$25M
-123.9% margin
Net Income
-$20M
-97.9% margin
EPS (Diluted)
$-0.62
Cash Flow
Operating Cash Flow
-$28M
Free Cash Flow
-$28M
Stock-Based Comp.
$10M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$20M
$25M
-16.6%
Gross Profit
-$14M
-$2M
-712.2%
Operating Income
-$25M
-$7M
-275.9%
Net Income
-$20M
-$8M
-145.0%
← Q4 2017
All Quarters
Q4 2018 →